Cabaletta Bio (CABA) Gets a Buy from H.C. Wainwright

Tip Ranks
2025.11.11 11:55
portai
I'm PortAI, I can summarize articles.

H.C. Wainwright analyst Douglas Tsao has reiterated a Buy rating on Cabaletta Bio (CABA) with a price target of $16.00. Tsao, a 5-star analyst, has an average return of 22.0% and a success rate of 53.85%. The analyst consensus for Cabaletta Bio is a Strong Buy, with a price target consensus of $18.40.

H.C. Wainwright analyst Douglas Tsao reiterated a Buy rating on Cabaletta Bio today and set a price target of $16.00.

Meet Your ETF AI Analyst

  • Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
  • Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.

According to TipRanks, Tsao is a 5-star analyst with an average return of 22.0% and a 53.85% success rate. Tsao covers the Healthcare sector, focusing on stocks such as Protagonist Therapeutics, Hansa Biopharma AB, and Alkermes.

Cabaletta Bio has an analyst consensus of Strong Buy, with a price target consensus of $18.40.

Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer